BioXcel Therapeutics Inc (NASDAQ:BTAI)
| 48.40 Delayed Data As of Sep 18 |  +0.11 / +0.23%Today’s Change | 3.76 Today|||52-Week Range 71.50 | +231.28% Year-to-Date |
Latest BTAI News | Press Releases
No recent news for BioXcel Therapeutics Inc.
Today’s Trading
| Previous close | 48.29 |
| Today’s open | 48.48 |
| Day’s range | 47.63 - 49.24 |
| Volume | 34,666 |
| Average volume (3 months) | 623,204 |
| Market cap | $1.1B |
Data as of 3:59pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | -53.05% |
| Earnings growth (this year) | -69.87% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 32.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TBIOTranslate Bio Inc | +0.04 | +0.27% |
| ARVNArvinas Inc | +1.18 | +4.40% |
| ALECAlector Inc | -0.02 | -0.14% |
| RGNXRegenxbio Inc | +0.39 | +1.32% |
Data as of 4:08pm ET, 09/18/2020
Financials
| Next reporting date | November 6, 2020 |
| EPS forecast (this quarter) | -$0.80 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$33.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
